On November 21, approximately 110 participants, including CEO Naito, Professor Ikujiro Nonaka (Professor Emeritus, Hitotsubashi University), Outside Directors, senior management and hhc managers from various Eisai subsidiaries worldwide, assembled at our global head office in Tokyo to participate in “hhc Initiative 2017.”
hhc Initiative is an annual event that promotes and recognizes excellence in innovative activities based on our hhc corporate philosophy. Each year, the most outstanding initiatives are selected from a range of innovative projects by Eisai employees, covering diverse hhc Driven activities that aim to realize various contributions to patients, case reports and proposals submitted by internal applicants (known as the “Eisai Innovation Paper”), as well as achievements of in-house R&D and production organizations. The overall aim of the event is to increase the understanding of the importance of innovative initiatives that emphasize health care from the patients' perspective, and by sharing these results to promote further innovation.
This year's hhc Initiative featured presentations on a total of 16 innovative activity themes. Of these, we would like to highlight a selection of activities by our Indonesian sales branch, PT Eisai Indonesia (“Eisai Indonesia”), which won our Award of hhc Excellence and by our China sales branch, Eisai China Inc (“Eisai China”), which won the Award for Excellence of Eisai Innovation Paper.